Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Buys Fermentas for $260M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today announced it has signed a definitive agreement to buy reagents manufacturer Fermentas International for $260 million in cash.

The deal is expected to close in the third quarter and is not anticipated to have a material impact on Thermo Fisher's 2010 financial results, the company said in a statement.

Based in Burlington, Ontario, with principal operations in Vilnius, Lithuania, Fermentas employs about 500. In 2009, it posted revenues of about C$57 million ($54 million).

Among the products offered by Fermentas are reagents for nucleic acid and protein purification, restriction and modifying enzymes, molecular weight markers, and other life science research and diagnostic tools. It also offers various products for polymerase chain reaction, reverse transcription PCR, and quantitative PCR.

The acquisition of Fermentas will allow Thermo Fisher to better meet the demands of cellular and molecular biologists "for complete workflows that can accelerate their research and improve results," said Marc Casper, president and CEO of Thermo Fisher.

In March, Thermo Fisher completed its acquisition of Finnzymes, whose product portfolio includes proprietary DNA polymerases. Together, the Fermentas and Finnzymes acquisitions, along with the recent launch of Thermo Fisher's Solaris qPCR assay "enables us to strengthen our depth of capabilities in the high-growth PCR market," Casper added in the statement.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.